Anti-CD19
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) (NCT07043946) | Climb Bio, Inc. | 2025-06-30 |
Track Anti-CD19 automatically
Every clearance here is in the API, with alerts when new ones post.